Guardant Health, Inc. (GH) Cash Flow Statement
Guardant Health, Inc. (GH) generated -$185.2M of operating cash flow over the twelve months to 2026-06-30, spent $55.5M on capital expenditure and had free cash flow of -$240.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GHGuardant Health, Inc.Follow GH — free
—
Price chart with a free account
- Market cap
- 22.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.05 | -0.10 | -0.21 | -0.31 | -0.32 | -0.24 | -0.18 | -0.19 | |
| Capital expenditure | 0.02 | 0.04 | 0.08 | 0.08 | 0.02 | 0.04 | 0.05 | -0.06 | |
| Free cash flow | -0.07 | -0.14 | -0.28 | -0.39 | -0.35 | -0.27 | -0.23 | -0.24 | |
| Dividends paid | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Share repurchases | 0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.05 | — | |
| Stock-based compensation | 0.02 | 0.14 | 0.15 | 0.09 | 0.09 | 0.14 | 0.17 | — |
USD billions · SEC XBRL
Guardant Health, Inc. — questions
- What is Guardant Health, Inc.'s operating cash flow?
- -$185.2M over the twelve months to 2026-06-30.
- How much does Guardant Health, Inc. spend on capital expenditure?
- $55.5M over the twelve months to 2026-06-30.
- What is Guardant Health, Inc.'s free cash flow?
- -$240.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Guardant Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.